Trump touts Medicaid drug savings
All 50 states, Washington, D.C. and Puerto Rico have applied to participate in an arrangement intended to give lower drug prices to Medicaid programs, President Trump said Friday. “This one thing alone should win us the midterms,” Trump told reporters in the Oval Office. Forty states and Puerto Rico have already signed agreements, the Centers...
President Trump announced that all 50 US states, Washington D.C., and Puerto Rico have applied to participate in a program aimed at reducing drug prices for Medicaid programs. According to Trump, this initiative alone could be enough to secure wins in the midterms. The program, known as GENEROUS, involves pharmaceutical companies providing supplemental rebates to align Medicaid net prices with those in other countries.
The White House estimates that this program will save $64.3 billion in federal and state government spending. However, health policy experts question whether these savings will directly benefit Medicaid patients, as they already pay low prices for their medications. Some experts, such as Brian Reid of Reid Strategic, argue that the program may only provide a small benefit to Medicaid programs themselves, rather than patients.
The details of the program, including which specific drugs are included and which states will take the pricing for which drugs, are still unclear. Some experts, like Peter Maybarduk of Public Citizen, have also raised questions about the Trump administration's 10-year estimate of savings, citing the confidential nature of the drug pricing deals.
Brief written by urgent.news from The Hill, Semafor, Endpoints News, STAT News, Fortune — 5 reports on this story. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
